Cibus, Inc. (CBUS) vs Seer, Inc. (SEER)

Cibus, Inc. and Seer, Inc. are both Biotechnology companies. Cibus, Inc. and Seer, Inc. are of similar size ($94.8M and $94.1M). Cibus, Inc. grew revenue faster over the last twelve months: −10.3% against −12.7%. Seer, Inc. has the higher net margin (−478.1% vs −2,258.9%) and the lower return on invested capital (−60.8% vs 0.00%). Across the 18 metrics below, Seer, Inc. leads on 13 and Cibus, Inc. on 5.

Valuation

Metric CBUS SEER Biotechnology median
P/E n/m n/m 10.26
P/S 20.48 6.36 9.18
P/B 6.02 0.40 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.97 0.65
EV/Sales 16.03 (4.39) 8.98
Earnings yield (142.24%) (74.39%) (34.89%)
Free cash flow yield (51.98%) (48.61%) (24.52%)

Profitability

Metric CBUS SEER Biotechnology median
Gross margin 100.00% 47.70% 65.16%
Operating margin (1,450.59%) (498.19%) 0.00%
Net margin (2,258.89%) (478.05%) 0.00%
Free cash flow margin (1,064.60%) (309.34%) 0.00%
Return on equity (219.97%) (26.45%) (50.12%)
Return on assets (29.77%) (23.47%) (45.60%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric CBUS SEER Biotechnology median
Revenue growth (TTM) (10.30%) (12.71%) 6.26%
EPS growth (last fiscal year) 74.33% 7.91% 29.88%
Revenue growth, 5-year CAGR (31.34%) 90.78% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBUS SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 14.74 4.89
Net debt to EBITDA (0.28) 2.63 1.01

Dividend

Metric CBUS SEER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CBUS SEER Biotechnology median
Market cap 94.77m 94.13m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack